Flagship Ventures Fund IV-Rx, L.P.'s Net Worth
$0
Who is Flagship Ventures Fund IV-Rx, L.P.?
Flagship Ventures Fund IV-Rx, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Moderna, Inc., Seres Therapeutics, Inc., Editas Medicine, Inc., Rubius Therapeutics, Inc., Syros Pharmaceuticals, Inc., Eleven Biotherapeutics, Inc., Axcella Health Inc., and Evelo Biosciences, Inc..
SEC CIK
Flagship Ventures Fund IV-Rx, L.P.'s CIK is 0001590973
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Moderna, Inc. (MRNA) Snapshot price: $72.23
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -36.29% | -11.05M |
—
|
—
| 19.41M |
Aug 17
| |||
Form 4
| -1.71% | -1.00M |
$68.22 | -$68,219,276.30 | 57.31M |
May 21 - May 22
| |||
Form 4
| -29.46% | -12.28M |
—
|
—
| 29.41M |
May 11
| |||
Form 4
| -5.75% | -9.67M |
$18.87 | -$8,196,935.61 | 158.57M |
Dec 9 - Dec 11
| |||
Form 4
|
∞
| 47.34M |
—
|
—
| 47.34M |
Dec 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Seres Therapeutics, Inc. (MCRB) Snapshot price: $1
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -39.84% | -7.91M |
—
|
—
| 11.94M |
Nov 23
| |||
Form 4
| -12.02% | -2.00M |
$27.60 | -$27,600,000.00 | 14.64M |
May 25
| |||
Form 4
|
∞
| 11.63M |
—
|
—
| 11.63M |
Jun 25 - Jun 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Editas Medicine, Inc. (EDIT) Snapshot price: $3.57
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -30.97% | -1.55M |
—
|
—
| 3.46M |
Aug 11
| |||
Form 4
|
∞
| 4.96M |
—
|
—
| 4.96M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Rubius Therapeutics, Inc. (RUBY) Snapshot price: $0.053
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +185.29% | 33.3M |
—
|
—
| 51.27M |
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Syros Pharmaceuticals, Inc. (SYRS) Snapshot price: $1.6
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -35.64% | -1.66M |
—
|
—
| 2.99M |
Aug 17
| |||
Form 4
| +47.55% | 4.59M |
$12.50 | $5,000,000.00 | 14.25M |
Jul 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||